The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Proteomic Patterns of Nipple Aspirate Fluids Obtained by SELDI‐TOF: Potential for New Biomarkers to Aid in the Diagnosis of Breast Cancer
Open accessAbstract
Nipple aspirate fluid (NAF) has been used for many years as a potential non‐invasive method to identify markers for breast cancer risk or early detection. Because individual markers have not been optimal, we are exploring the use of surface enhanced laser desorption and ionization time of flight (SELDI‐TOF) mass spectrometry to identify patterns of proteins that might define a proteomic signature for breast cancer. SELDI‐TOF was used to analyze a study set of NAF samples that included 12 women with breast cancer and 15 healthy controls (the latter included three women with an abnormal mammogram but subsequent normal biopsy). In this preliminary report, we present data showing that SELDI analysis of NAF is rapid, reproducible, and capable of identifying protein signatures that appear to differentiate NAF samples from breast cancer patients and healthy controls, including those with an abnormal mammogram who were later proven to be biopsy normal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Khan, J., Wei, J. S., Ringnér, M., Saal, L. H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C. R., Peterson, C., et al. (2001) · Nature Medicine · doi:10.1038/89044 · Cited by 2,644
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D.-S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,072
Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations
Elmore, J. G., Barton, M. B., Moceri, V. M., Polk, S., Arena, P. J., & Fletcher, S. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804163381601 · Cited by 1,053
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Direct Profiling of Proteins in Biological Tissue Sections by MALDI Mass Spectrometry
Chaurand, P., Stoeckli, M., & Caprioli, R. M. (1999) · Analytical Chemistry · doi:10.1021/ac990781q · Cited by 282
Sauter, E., Ross, E., Daly, M., Klein-Szanto, A., Engstrom, P., Sorling, A., Malick, J., & Ehya, H. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.415 · Cited by 186
Lacey, J. M., Bergen, H. R., Magera, M. J., Naylor, S., & O’Brien, J. F. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.513 · Cited by 179
Evaluation of a Palpable Breast Mass
Desforges, J. F., & Donegan, W. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209243271307 · Cited by 151
Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk.
Sauter, E. R., Daly, M., Linahan, K., Ehya, H., Engstrom, P. F., Bonney, G. E., Ross, E. A., Yu, H., & Diamandis, E. P. (1996) · PubMed · Cited by 122
Nipple Aspirate Cytology for the Study of Breast Cancer Precursors 2
King, E. B., Chew, K., Petrakis, N., & Ernster, V. L. (1983) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/71.6.1115 · Cited by 79
Wrensch, M., Petrakis, N. L., King, E. B., Lee, M. M., & Miike, R. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116744 · Cited by 60
Petrakis, N. (1993) · PubMed · Cited by 47
Evaluation of IgG glycation levels by matrix-assisted laser desorption/ionization mass spectrometry
Lapolla, A., Fedele, D., Aronica, R., Garbeglio, M., D’Alpaos, M., Seraglia, R., & Traldi, P. (1997) · Rapid Communications in Mass Spectrometry · Cited by 43
Pharmacogenomics of cytochrome P450 and other enzymes involved in biotransformation of xenobiotics
Guengerich, F. P. (2000) · Drug Development Research · doi:10.1002/(sici)1098-2299(200001)49:1<34::aid-ddr6>3.0.co;2-w · Cited by 30
Nakanishi, T., Shimizu, A., Okamoto, N., Ingendoh, A., & Kanai, M. (1995) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(95)00326-9 · Cited by 21
Prognostic Markers in Localized Prostate Cancer: From Microscopes to Molecules
Harding, M. A., & Theodorescu, D. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006137721823 · Cited by 15
Cited by
Proteomic applications for the early detection of cancer
Wulfkuhle, J. D., Liotta, L. A., & Petricoin, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1043 · Cited by 907
Self-citationLi, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y., & Chan, D. W. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1296 · Cited by 893
Proteomic patterns of tumour subsets in non-small-cell lung cancer
Yanagisawa, K., Shyr, Y., Xu, B. J., Massion, P. P., Larsen, P. H., White, B. C., Roberts, J. R., Edgerton, M., Gonzalez, A., Nadaf, S., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14068-8 · Cited by 602
Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells
Pigati, L., Yaddanapudi, S. C. S., Iyengar, R., Kim, D.-J., Hearn, S. A., Danforth, D., Hastings, M. L., & Duelli, D. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013515 · Cited by 582
Human body fluid proteome analysis
Hu, S., Loo, J. A., & Wong, D. T. (2006) · PROTEOMICS · doi:10.1002/pmic.200600284 · Cited by 533
Metadata
- Authors
- Paweletz, C. P., Trock, B., Pennanen, M., Tsangaris, T., Magnant, C., Liotta, L. A., & Petricoin, E. F.
- Venue
- Disease Markers
- Publisher
- Wiley
- Published
- 2001-01
- Volume
- 17
- Issue
- 4
- Pages
- 301-307
- ISSN
- 0278-0240 (ISSN-L)
- 1875-8630
- OpenAlex
- W2102260352
- Cited by
- 285
- References
- 16
- FWCI
- 13.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.